- Argenx to pick up autoimmune biotech Forte Biosciences for $2.2BArgenx will spend $2.2 billion to buy Forte Biosciences and its anti-CD122 monoclonal antibody that’s under investigation for autoimmune diseases. The Belgian-Dutch pharma said Monday it will pay…Endpoints · 9h ago↗ source
- From confidence to capital: Positioning biotech for the next growth cycle<p>How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.</p>BioPharma Dive · 11h ago↗ source
- Denmark’s foundation‑fueled biotech boom redraws the Nordic mapInvestment and a maturing talent base have propelled Denmark ahead of its Nordic peers, drawing Swedish companies and exposing regional gaps in capital and scale.BioSpace